Can you inject Mounjaro into the back of the arm?

Is the back of the upper arm actually licensed for Mounjaro?

It is. The Mounjaro SmPC lists the abdomen, the front of the thigh and the back of the upper arm as the three approved subcutaneous injection sites. You can confirm the exact wording in the Mounjaro SmPC on the eMC, which is the definitive reference for storage, injection guidance and contraindications. The back of the arm is not a workaround or a patient-led shortcut, it is there in the prescribing information from the start.

That said, the triceps area is less common than the abdomen among people new to self-injection, mainly because it is harder to see and reach. Once people get comfortable with the technique, many find it a useful addition to their rotation, the abdomen can become tender if it carries every single weekly dose.

A note on what "back of the upper arm" means in practice: aim for the fleshy, fatty area at the back of the arm, roughly halfway between the shoulder and the elbow. Avoid the bony outer edge of the shoulder and stay clear of the elbow. The needle should go straight in at a 90-degree angle, or at a slight angle if you have less fatty tissue there, the KwikPen's needle length is designed for subcutaneous (under the skin, not into muscle) delivery.

How do you actually reach the back of your own arm?

This is a question our prescribers hear most weeks. The honest answer is that it requires a small amount of setup the first time. A few approaches that work:

Stand sideways in front of a full-length or bathroom mirror. Raise your injecting arm slightly and brace it against a wall or door frame to steady it. The mirror lets you see the site and confirm placement before pressing the button. Alternatively, some people rest the back of their arm on the edge of a firm surface (a countertop, for instance) to keep it still while the other hand positions the pen.

If you live with someone, asking them to administer the injection occasionally (they do not need clinical training to press a KwikPen button, but they should read the instructions in the leaflet first) takes the coordination out of it entirely.

The KwikPen itself requires only light pressure to activate, so there is no need to grip the arm tightly or stretch the skin significantly. If you notice bruising, lumps or persistent soreness at the back of the arm, rotate away from that site for a few weeks and mention it to your prescriber. You can find more general guidance on injecting Mounjaro into the arm, including tips on confirming you have the right spot.

Why does site rotation matter, and what happens if you skip it?

Rotating injection sites is not just a preference; it protects tissue integrity and may affect how consistently the medicine absorbs. Injecting repeatedly into the same small patch of skin can cause lipohypertrophy, a thickening or lumpiness of the fatty layer beneath the skin. Insulin users know this problem well; the same principle applies to GLP-1 and dual-agonist medicines. Injecting into an area of lipohypertrophy can reduce absorption and blunt the medicine's effect, which matters when you are working through a titration schedule.

The practical rule is to move at least 5 cm from where you injected the previous week within the same site, and to cycle through the available sites over time. So: right thigh one week, left abdomen the next, back of the right arm the week after, and so on, though the exact rotation is flexible. What matters is avoiding repeated use of an identical spot.

If back pain or general discomfort is something you experience around injection days, it is worth separating that from injection-site tenderness, and our page on how Mounjaro can be linked to back pain covers the distinction. Injection-site reactions (redness, mild swelling, brief stinging) are common and typically short-lived. More persistent or unusual skin changes should be flagged to your prescriber.

Are there situations where the back of the arm is the better choice?

Sometimes, yes. People who have recently had abdominal surgery, or who have scar tissue or skin conditions in the abdominal area, may find the upper arm or thigh more practical. The back of the arm can also be useful if both thighs are sore from recent doses and a rest period makes sense.

There is limited head-to-head pharmacokinetic data comparing all three sites specifically for tirzepatide, so the guidance sticks to equivalence, all three sites produce acceptable subcutaneous absorption when technique is correct. The NHS medicines page for tirzepatide reinforces that any of the three approved sites is suitable, with rotation as the constant recommendation.

One thing to be clear about: the injection must be subcutaneous. If the back of your arm has very little fatty tissue, the thigh or abdomen may be more reliable, and if you have been noticing a back ache that seems to coincide with your Mounjaro doses, that is worth discussing with your prescriber before settling on any single site as your default. Your prescriber can advise on this as part of your ongoing clinical review. If you are curious about how treatment fits into the broader weight-loss picture, our overview of weight-loss treatment options sets out where Mounjaro sits alongside other licensed medicines.

For anything specific about how your current doses or site choices are working, reaching our clinical team is straightforward via the contact page. And if you are not yet on treatment, readers who are also wondering whether Mounjaro can cause back pain may find it useful to review that before their first consultation, as our prescribers review every application the same day it arrives. Those who have previously used Mounjaro and are considering restarting can also read our guide to going back on Mounjaro, which covers what to expect when resuming treatment after a break.